Best Lancet Infectious Diseases Podcasts (2024)

1
Highlights July 2024 EID, MMWR, J of Infection, Eurosurveillance, Nature, JAMA Forum 24:35

14d ago24:35

24:35

Email us at contact@closecontact.info By way of overview, this month we have: First, from the July Emerging Infectious Diseases Journal, an article describing the reemergence of Clade IIb–Associated Mpox, in Germany in 2023. Next, From the July Emerging Infectious Diseases Journal, a study describing the discovery of both avian and human-like siali…

1
In conversation with... Bola Owolabi 34:06

2M ago34:06

34:06

Prof. Bola Owolabi, Director of the National Healthcare Inequalities Improvement Programme at NHS England, speaks to Zoë Mullan about overcoming inertia, using data for action, and global health as a truly global - rather than LMIC - issue.By The Lancet

1
Highlights June 2023 from EID, Nature Communications, Clinical Microbiology Reviews 33:40

3M ago33:40

33:40

Overview and links to articles mentioned this month. www.closecontact.info Email: contact@closecontact.info June 2024, Emerging Infectious Diseases: Noelle M. Cocoros details the development of the RAVIOLI algorithm, a new method using electronic health records to enhance surveillance of respiratory viruses beyond traditional influenza-like illness…

1
In conversation with... Kara Hanson 25:03

3M ago25:03

25:03

Zoë Mullan talks to Prof Kara Hanson of the UK’s National Institute for Health and Care Research and Dr Michael Makanga of the European and Developing Countries Clinical Trials Partnership on funding for research involving collaborators in the Global North and Global South and how it can be made more equitable.…

1
Highlights May 24 - from EID, JID, Lancet ID, Am Journal of Infection Control 26:20

3M ago26:20

26:20

By way of overview, first up a study in May Emerging Infectious Diseases providing a detailed description of Hepatitis E viral dynamics in a group of asymptomatic people tested every 4 days, showing rapid viral load rises and declines with parallel antibody responses. Next, a report in May EID of a cluster of invasive meningococcal disease caused b…

1
In conversation with... Michael Udedi and Kazione Kulisewa 25:55

4M ago25:55

25:55

Liam Messin, of The Lancet Global Health, speaks to Michael Udedi and Kazione Kulisewa about implementation science and mental health in Malawi.By The Lancet

1
Highlights April 2024 -EID, Eurosurveillance, MMWR 34:52

5M ago34:52

34:52

Welcome to our selected article summaries from some great public health journals including the April 2024 issue of the CDC's Emerging Infectious Diseases Journal, March Eurosurveillance, and other leading journals. From the April issue of Emerging Infectious Diseases, we will cover: A report on deaths associated with pediatric hepatitis of unknown …

1
In conversation with... Kathy Baisley and Ruanne Barnabas 20:37

5M ago20:37

20:37

Georgia Bisbas of The Lancet Global Health talks to Kathy Baisley and Ruanne Barnabas about their trials on immunobridging and HPV vaccine efficacy in Tanzania and Kenya.By The Lancet

1
HIghlights March '24 from EID, Eurosurveillance & Nature Communications 27:33

6M ago27:33

27:33

Hello, and welcome to our selected article summaries from the March 2024 issue of the CDC's Emerging Infectious Diseases Journal, February Eurosurveillance, and Nature Communications. First up, we explore a significant study published in the March issue of Emerging Infectious Diseases journal,by Pablo I. Plaza and colleagues, revealing a worrying t…

1
In Conversation With… Prasad Kulkarni on a dengue monoclonal antibody 18:53

6M ago18:53

18:53

Prasad Kulkarni discusses a new Phase I trial in The Lancet Infectious Diseases on a dengue monoclonal antibody also known as VIS513 in healthy adults. In addition, he highlights the wider implications of this for dengue control and drug development.By The Lancet

1
Prasad Kulkarni on dengue monoclonal antibodies 18:53

6M ago18:53

18:53

Prasad Kulkarni discusses a new Phase I trial in The Lancet Infectious Diseases on a dengue monoclonal antibody also known as VIS513 in healthy adults. In addition, he highlights the wider implications of this for dengue control and drug development. Read the full article: https://www.thelancet.com/journals/laninf/article/ S1473-3099(24)00030-6/ful…

1
Highlights Feb 24 Emerging Infectious Diseases Journal 19:05

6M ago19:05

19:05

Welcome to this episode of our public health podcast, where we delve into the latest research findings from the February 2024 issue of the Emerging Infectious Diseases journal. Today, we're covering a range of critical topics that underscore the evolving landscape of infectious diseases and our responses to them. Let's take a brief look at what's c…

1
In conversation with... Authia Gray and Kevin Ikuta 14:35

7M ago14:35

14:35

Lauren Southwell of The Lancet Global Health talks to Authia Gray and Kevin Ikuta about the burden of bacterial antimicrobial resistance in the WHO African region during 2019.By The Lancet

1
In conversation with... Oriol Mitjà 15:25

7M ago15:25

15:25

Oriol Mitjà discusses a new trial in The Lancet Infectious Diseases on the use of oral linezolid compared with benzathine penicillin G for the treatment of early syphilis in adults. He also highlights what the trial means for treatment of syphilis.By The Lancet

1
Oriol Mitjà on treatment of early syphilis in adults 15:25

7M ago15:25

15:25

Oriol Mitjà discusses a new trial in The Lancet Infectious Diseases on the use of oral linezolid compared with benzathine penicillin G for the treatment of early syphilis in adults. He also highlights what the trial means for treatment of syphilis. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00683-7/ful…

1
In conversation with... Sofia Viegas and Stefan Niemann 24:35

9M ago24:35

24:35

Sofia Viegas and Stefan Niemann discuss a new article in The Lancet Infectious Diseases about emerging bedaquiline resistance in Mozambique and its implications for drug resistant tuberculosis and the fight to end tuberculosis.By The Lancet

1
Sofia Viegas and Stefan Niemann on emerging bedaquiline resistance in Mozambique 24:35

9M ago24:35

24:35

Sofia Viegas and Stefan Niemann discuss a new article in The Lancet Infectious Diseases about emerging bedaquiline resistance in Mozambique and its implications for drug resistant tuberculosis and the fight to end tuberculosis. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00498-X/fulltext?dgcid=buzzsprou…

1
In conversation with... Clara Frick and Isabelle Soerjomataram 15:31

10M ago15:31

15:31

Fio Trethewey of The Lancet Global Health talks to Clara Frick and Dr Isabelle Soerjomataram about their research on premature cancer mortality which included a population-based study looking into preventable and treatable deaths from 36 cancers worldwide.By The Lancet

1
In conversation with... Madeline Ballard and Biziwiek Maliton 14:05

11M ago14:05

14:05

Amana Baig of The Lancet Global Health talks to Dr Madeline Ballard and Biziwiek Malitoni about the labour exploitation of community health worker systems.By The Lancet

1
In conversation with... Carolina Coll and Joe Murray 18:47

1y ago18:47

18:47

Liam Messin of The Lancet Global Health talks to Dr Carolina Coll and Joe Murray about their research investigating the association between maternal parenting and intimate partner violence.By The Lancet

1
In conversation with... Rizwana Chaudhri and Ian Roberts 17:45

1y ago17:45

17:45

Liam Messin of The Lancet Global Health talks to Professor Rizwana Chaudhri and Professor Ian Roberts about their research investigating the association between maternal anaemia and post-partum haemorrhage.By The Lancet

1
In conversation with... Xiang Wu and Maha Aon 25:32

1y ago25:32

25:32

Liam Messin of The Lancet Global Health talks to Xiang Wu and Maha Aon, who recently served as guest editors for the 10th Anniversary issue of The Lancet Global Health, about successes and challenges in the field of global health.By The Lancet

1
In conversation with... Hasbullah Thabrany and Augustine Asante 24:11

1+ y ago24:11

24:11

Nina Putnis of The Lancet Global Health talks to Prof. Hasbullah Thabrany and Dr Augustine Asante about Indonesia’s national health insurance scheme and how its benefits and challenges impact especially the country’s poorest. This has important lessons for other Governments across the world also seeking to understand Universal Health Coverage.…

1
In conversation with... Simon Wigley and Luke Allen 18:15

1+ y ago18:15

18:15

Liam Messin of The Lancet Global Health talks to Professor Simon Wigley and Dr Luke Allen about their research investigating the implementation of global non-communicable disease policy worldwide.By The Lancet

1
In conversation with... Pamela Jeyaraj and Stephen Knight 16:38

1+ y ago16:38

16:38

Nina Putnis of The Lancet Global Health speaks to Professor Pamela Jeyaraj and Mr Stephen Knight about their research understanding the link between malnutrition and outcomes after surgery for bowel cancer across 75 countries.By The Lancet

1
In conversation with... Luciano Moreira and Henrik Salje 17:01

1+ y ago17:01

17:01

Luciano Moreira and Henrik Salje discuss a new article in The Lancet Infectious Diseases describing the use of the Wolbachia bacteria to control the spread of mosquito-borne dengue and chikungunya in Rio de Janeiro, Brazil.By The Lancet

1
In conversation with... Refiloe Masekela and Luis Garcia-Marcos 19:36

1+ y ago19:36

19:36

Liam Messin of The Lancet Global Health talks to Associate Prof Refiloe Masekela and Prof Luis Garcia-Marcos about their research investigating the control and management of asthma worldwide.By The Lancet

1
Louis Pasteur special edition: Rabies 29:00

1+ y ago29:00

29:00

Louis Pasteur was involved in the creation of the first rabies vaccine in the 1880s, but today one person every ten minutes still dies from rabies, with all of the deaths concentrated in low and middle-income countries. Prof. Katie Hampson joins Gavin and Jessamy to talk about the history of the vaccine and why it's proven so difficult to eliminate…

1
In conversation with... Martha Mushi and Dominique Green 16:44

1+ y ago16:44

16:44

Nina Putnis of The Lancet Global Health speaks to Dr Martha Mushi and Dr Dominique Green about their research assessing the impact of multidimensional poverty on the self-medication and non-adherence of antibiotics in Tanzania, Kenya and Uganda and the links to antimicrobial resistance.By The Lancet

1
In conversation with... Kate Grabowski and Joseph Kagaayi 21:20

2y ago21:20

21:20

Liam Messin of The Lancet Global Health talks to Dr Kate Grabowski and Dr Joseph Kagaayi about their research investigating the HIV and STI syndemic in southern Uganda.By The Lancet

1
In conversation with... Manoj Murhekar and William Moss 20:16

2y ago20:16

20:16

Nina Putnis of The Lancet Global Health talks to Dr Manoj Murhekar and Prof William Moss about their research using seroprevalence to understand the impact of Measles and Rubella campaigns in India.By The Lancet

1
Luciano Moreira and Henrik Salje on Wolbachia control of mosquito-borne infections 17:01

2y ago17:01

17:01

Luciano Moreira and Henrik Salje discuss a new article in The Lancet Infectious Diseases describing the use of the Wolbachia bacteria to control the spread of mosquito-borne dengue and chikungunya in Rio de Janeiro, Brazil. Read the full article: Estimating the effect of the wMel release programme on the incidence of dengue and chikungunya in Rio d…

1
Richard Maude on malaria chemoprophylaxis in Cambodia 12:44

2y ago12:44

12:44

Richard Maude discusses a new article in The Lancet Infectious Diseases that assesses the efficacy of malaria chemoprophylaxis among forest goers in Cambodia. Read the full article: Antimalarial chemoprophylaxis for forest goers in southeast Asia Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://insta…

1
In conversation with... Richard Maude 12:44

2y ago12:44

12:44

Richard Maude discusses a new article in The Lancet Infectious Diseases that assesses the efficacy of malaria chemoprophylaxis among forest goers in Cambodia.By The Lancet

1
Ben Cowling on COVID-19 vaccines in Hong Kong 20:58

2y ago20:58

20:58

Ben Cowling discusses a new article in The Lancet Infectious Diseases describing the protection that vaccines are providing against COVID-19 in Hong Kong. Read the full article: Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong Continue this conversation on social! Follow us today at... https…

1
In conversation with... Ben Cowling 20:58

2y ago20:58

20:58

Ben Cowling discusses a new article in The Lancet Infectious Diseases describing the protection that vaccines are providing against COVID-19 in Hong Kong.By The Lancet

1
In conversation with... Olusegun Alatise 14:27

2y ago14:27

14:27

Mandip Aujla talks to Olusegun Alatise about colorectal cancer screening in Nigeria.By The Lancet

1
Hugh Adler on monkeypox in the UK 18:17

2y ago18:17

18:17

Hugh Adler discusses a new article in The Lancet Infectious Diseases describing the management and the clinical features for seven patients with monkeypox hospitalised in the UK between 2018 and 2021. Read the full article: Clinical features and management of human monkeypox: a retrospective observational study in the UK Continue this conversation …

1
In conversation with... Hugh Adler 18:17

2y ago18:17

18:17

Hugh Adler discusses a new article in The Lancet Infectious Diseases describing the management and the clinical features for seven patients with monkeypox hospitalised in the UK between 2018 and 2021.By The Lancet

1
In conversation with... Melanie Lowe and Deepti Adlakha 21:04

2+ y ago21:04

21:04

Nina Putnis talks to two of the authors of the new Series on urban design, transport, and health, Melanie Lowe and Deepti Adlakha.By The Lancet

1
In conversation with... Kara Hanson 19:19

2+ y ago19:19

19:19

Zoë Mullan talks to lead author Kara Hanson about the main findings and recommendations of the Commission on financing primary health care.By The Lancet

1
In conversation with... Rashidatu Kamara and Tom Wingfield 23:57

2+ y ago23:57

23:57

Nina Putnis talks to Rashidatu Kamara and Tom Wingfield about their new research on the social and health factors associated with adverse treatment outcomes among people with MDR-TB in Sierra Leone.By The Lancet

1
In conversation with... Sanjib Kumar Sharma 13:58

2+ y ago13:58

13:58

Mandip Aujla talks to Sanjib Kumar Sharma about the epidemiology of snakebite in the Terai region of Nepal.By The Lancet

1
In conversation with... Beate Kampmann, Karen Keddy, and Peter Ghazal 22:16

2+ y ago22:16

22:16

Prof Beate Kampmann, Dr Karen Keddy, and Prof Peter Ghazal discuss a new cross-journal Series in The Lancet Infectious Diseases and EBioMedicine addressing the potential for and challenge of applying big data to childhood infectious diseases in LMICsBy The Lancet

1
Beate Kampmann, Karen Keddy, and Peter Ghazal on applying big data to childhood infectious diseases in LMICs 22:16

2+ y ago22:16

22:16

Prof Beate Kampmann, Dr Karen Keddy, and Prof Peter Ghazal discuss a new cross-journal Series in The Lancet Infectious Diseases and EBioMedicine addressing the potential for and challenge of applying big data to childhood infectious diseases in LMICs. Read the full Series: https://www.thelancet.com/series/big-data-childhood-infections-LMICs Continu…

1
In conversation with... Leo Martinez and Heather Zar 16:00

3y ago16:00

16:00

Iman Wright talks to Leo Martinez and Heather Zar about their new research on cytomegalovirus acquisition and the risk of TB disease in childhood in South Africa.By The Lancet

1
In conversation with... Juliet Mwanga-Amumpaire 10:54

3y ago10:54

10:54

Mandip Aujla talks to Juliet Mwanga-Amumpaire about the effectiveness of traditional healers in delivering HIV tests to adults in rural Uganda.By The Lancet

1
Laura Cooper and Sam Okiror on polio eradication in Africa 21:34

3y ago21:34

21:34

A new article highlights how changing immunity profiles motivate the need for better responses to outbreaks of polio in Africa. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00453-9/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/the…

1
In conversation with... Laura Cooper and Sam Okiror 21:34

3y ago21:34

21:34

A new Article in The Lancet Infectious Diseases highlights how changing immunity profiles motivate the need for better responses to outbreaks of polio in Africa.By The Lancet

Podcasts Worth a Listen

Lancet Infectious Diseases Podcasts

Podcasts Worth a Listen

Quick Reference Guide